CRISPR to fix bad blood: a new tool in basic and clinical hematology

Advances in genome engineering in the last decade, particularly in the development of programmable nucleases, have made it possible to edit the genomes of most cell types precisely and efficiently. Chief among these advances, the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Romero, Elisa, Martínez-Valiente, Cristina, García-Ruiz, Cristian, Vázquez-Manrique, Rafael P., Cervera, José, Sanjuan-Pla, Alejandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518885/
https://www.ncbi.nlm.nih.gov/pubmed/30923099
http://dx.doi.org/10.3324/haematol.2018.211359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518885/
https://www.ncbi.nlm.nih.gov/pubmed/30923099
http://dx.doi.org/10.3324/haematol.2018.211359

Ejemplares similares